Aclaris Therapeutics
ACRSAclaris Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small and large molecule therapies for immuno-inflammatory diseases.
Earnings
Next report
Nov 5, 2026 (in a month)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small and large molecule therapies for immuno-inflammatory diseases. The company utilizes its proprietary KINect drug discovery platform to identify product candidates with high target affinity and specificity, including covalent inhibitors and multi-specific antibodies. Its primary value proposition lies in advancing a pipeline of investigational treatments for conditions such as atopic dermatitis, asthma, and other T cell-mediated autoimmune disorders.
A clinical-stage innovator utilizing a specialized kinase discovery platform to develop potential best-in-class treatments for high-need inflammatory indications.
FAQ
- What is Aclaris Therapeutics's market cap?
- Aclaris Therapeutics (ACRS) has a market capitalization of $649.1M and trades on NASDAQ.
- What is Aclaris Therapeutics's revenue and profitability?
- Aclaris Therapeutics generated $8.2M in trailing twelve-month revenue with a net loss of $75.7M, representing a net margin of -921.5%. Gross margin stands at 79.5%, with free cash flow of -$62.2M. The latest reported period is Q2 2026.
- Who are Aclaris Therapeutics's competitors?
- Aclaris Therapeutics's key competitors include Corvus Pharmaceuticals, Incyte, UpStream Bio, and others. These companies compete in similar markets and product categories.
- Who does Aclaris Therapeutics partner with?
- Aclaris Therapeutics's notable partners include Biosion, Inc., CTTQ, Pediatrix Therapeutics, Inc., and others.
- What subsidiaries does Aclaris Therapeutics have?
- Aclaris Therapeutics's subsidiaries include Confluence, Aclaris Life Sciences, Inc..
- Where is Aclaris Therapeutics headquartered?
- Aclaris Therapeutics is headquartered in United States of America and employs approximately 91 people. It has been publicly traded since 2015.
